Chiltern Adopts ePharmaONE as its Site Management Platform
London, U.K., and Wilmington, N.C. - Chiltern, a leading global contract research organization, has adopted ePharmaOne™, a proprietary site management platform offered by ePharmaSolutions™, a leading provider of e-clinical solutions. This cloud-based platform improves collaboration with sites, enhances document quality and cycle times, and offers sponsors a paperless, virtual and mobile site management process with an integrated electronic trial master file. “Adding ePharmaOne to our Collaborative Technologies suite brings a new paperless approach necessary to meet regulatory standards and sponsor expectations. We continuously look to strengthen our Collaborative Approach, and this significantly improves the quality of our offerings,” said Jim Esinhart, PhD, Chiltern CEO. “We are excited to support our company focus with yet another way to make clients’ and sites’ jobs easier.” With ePharmaOne, Chiltern clients and sites will have turnkey site document management integrated with a state-of-the-art electronic trial master file (eTMF). This best-in-class technology truly gives Chiltern clients a “Designed Around You” experience. “Chiltern is leading the CRO industry in uptake of technology,” said Alison O’Neill, chief operating officer, ePharmaSolutions. “We are excited they have chosen ePharmaSolutions and are happy to be a part of their portfolio of technologies available to their clients.” The new platform provides an integrated solution for:
- Feasibility and site identification
- Secure document exchange, electronic signature and embedded document approvals
- Site learning management
- Electronic site safety letter distribution
- eTMF
Paragon Solutions, a leader in life sciences consulting services, is Chiltern’s implementation partner for ePharmaOne and has been instrumental in driving this implementation project to completion, on time and on budget. Chiltern is scheduling demos in Booth 601 at the Drug Information Association (DIA) Annual Meeting, June 26-30 in Philadelphia. See how this platform can work for your trial by
scheduling a meeting
at the show.
About Chiltern
Chiltern, a global contract research organization, is the leading mid-sized provider of clinical solutions in a variety of specialty areas and engagement models for biopharmaceutical and medical device industries. Chiltern’s team of more than 4,200, located across 47 countries, provides comprehensive Clinical Development, Medical & Scientific Affairs, Data & Analysis, Pharmacovigilance, Strategic Regulatory and Clinical Supplies services using a collaborative approach to maximize efficiency and minimize delays. Visit
Chiltern.com
to learn more about how Chiltern is Designed Around You.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
